Avery W Catlin - Net Worth and Insider Trading
Avery W Catlin Net Worth
The estimated net worth of Avery W Catlin is at least $590,989 dollars as of 2024-11-13. Avery W Catlin is the Director of Provention Bio Inc and owns about 20,000 shares of Provention Bio Inc (PRVB) stock worth over $499,600. Avery W Catlin is the Sr. VP & CFO of Celldex Therapeutics Inc and owns about 2,341 shares of Celldex Therapeutics Inc (CLDX) stock worth over $63,277. Avery W Catlin is also the Director of Corbus Pharmaceuticals Holdings Inc and owns about 1,567 shares of Corbus Pharmaceuticals Holdings Inc (CRBP) stock worth over $28,112. Details can be seen in Avery W Catlin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Avery W Catlin has not made any transactions after 2018-12-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Avery W Catlin
Avery W Catlin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Avery W Catlin owns 3 companies in total, including Provention Bio Inc (PRVB) , Corbus Pharmaceuticals Holdings Inc (CRBP) , and Celldex Therapeutics Inc (CLDX) .
Click here to see the complete history of Avery W Catlin’s form 4 insider trades.
Insider Ownership Summary of Avery W Catlin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PRVB | Provention Bio Inc | 2018-12-26 | director |
| CRBP | Corbus Pharmaceuticals Holdings Inc | 2017-05-11 | director |
| CLDX | Celldex Therapeutics Inc | 2015-11-23 | Sr. VP & CFO |
Avery W Catlin Latest Holdings Summary
Avery W Catlin currently owns a total of 3 stocks. Among these stocks, Avery W Catlin owns 20,000 shares of Provention Bio Inc (PRVB) as of December 26, 2018, with a value of $499,600 and a weighting of 84.54%. Avery W Catlin owns 2,341 shares of Celldex Therapeutics Inc (CLDX) as of November 23, 2015, with a value of $63,277 and a weighting of 10.71%. Avery W Catlin also owns 1,567 shares of Corbus Pharmaceuticals Holdings Inc (CRBP) as of May 11, 2017, with a value of $28,112 and a weighting of 4.76%.
Latest Holdings of Avery W Catlin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PRVB | Provention Bio Inc | 2018-12-26 | 20,000 | 24.98 | 499,600 |
| CLDX | Celldex Therapeutics Inc | 2015-11-23 | 2,341 | 27.03 | 63,277 |
| CRBP | Corbus Pharmaceuticals Holdings Inc | 2017-05-11 | 1,567 | 17.94 | 28,112 |
Holding Weightings of Avery W Catlin
Avery W Catlin Form 4 Trading Tracker
According to the SEC Form 4 filings, Avery W Catlin has made a total of 0 transactions in Provention Bio Inc (PRVB) over the past 5 years. The most-recent trade in Provention Bio Inc is the acquisition of 10,000 shares on December 26, 2018, which cost Avery W Catlin around $18,800.
According to the SEC Form 4 filings, Avery W Catlin has made a total of 0 transactions in Celldex Therapeutics Inc (CLDX) over the past 5 years. The most-recent trade in Celldex Therapeutics Inc is the sale of 1,667 shares on November 23, 2015, which brought Avery W Catlin around $450,000.
According to the SEC Form 4 filings, Avery W Catlin has made a total of 0 transactions in Corbus Pharmaceuticals Holdings Inc (CRBP) over the past 5 years. The most-recent trade in Corbus Pharmaceuticals Holdings Inc is the acquisition of 167 shares on May 11, 2017, which cost Avery W Catlin around $30,750.
Insider Trading History of Avery W Catlin
- 1
Avery W Catlin Trading Performance
GuruFocus tracks the stock performance after each of Avery W Catlin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Avery W Catlin is -0.96%. GuruFocus also compares Avery W Catlin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Avery W Catlin within 3 months outperforms 4 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Avery W Catlin's insider trading performs compared to the benchmark.
Performance of Avery W Catlin
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 6.85 | | | | | |
| Relative Return to S&P 500(%) | 6.77 | | | | | |
Avery W Catlin Ownership Network
Ownership Network List of Avery W Catlin
Ownership Network Relation of Avery W Catlin
Avery W Catlin Owned Company Details
What does Provention Bio Inc do?
Who are the key executives at Provention Bio Inc?
Avery W Catlin is the director of Provention Bio Inc. Other key executives at Provention Bio Inc include 10 percent owner Sessa Capital (master), L.p. , director & 10 percent owner & Chief Scientific Officer Francisco Leon , and director & 10 percent owner & President and CEO Ashleigh Palmer .
Provention Bio Inc (PRVB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Provention Bio Inc (PRVB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Provention Bio Inc (PRVB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Provention Bio Inc (PRVB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Provention Bio Inc Insider Transactions
Avery W Catlin Mailing Address
Above is the net worth, insider trading, and ownership report for Avery W Catlin. You might contact Avery W Catlin via mailing address: 241 Central Street, Hingham Ma 02043.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
